Avantor, Inc. (AVTR)
NYSE: AVTR · Real-Time Price · USD
13.53
-0.21 (-1.53%)
At close: Jun 27, 2025, 4:00 PM
13.53
0.00 (0.00%)
After-hours: Jun 27, 2025, 7:00 PM EDT
Avantor Employees
Avantor had 13,500 employees as of December 31, 2024. The number of employees increased by 5,930 or 78.34% compared to the previous year.
Employees
13,500
Change (1Y)
5,930
Growth (1Y)
78.34%
Revenue / Employee
$495,200
Profits / Employee
$53,007
Market Cap
9.22B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 13,500 | 5,930 | 78.34% |
Dec 31, 2023 | 7,570 | -6,930 | -47.79% |
Dec 31, 2022 | 14,500 | 1,000 | 7.41% |
Dec 31, 2021 | 13,500 | 1,100 | 8.87% |
Dec 31, 2020 | 12,400 | 400 | 3.33% |
Dec 31, 2019 | 12,000 | 0 | - |
Dec 31, 2018 | 12,000 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AVTR News
- 13 hours ago - Avantor® to Host Second Quarter 2025 Earnings Call on Friday, August 1, 2025 - PRNewsWire
- 20 hours ago - Avantor: Unloved Lab And Medical Testing Supplier Under Heavy Accumulation - Seeking Alpha
- 6 weeks ago - Avantor® to Participate in the 2025 RBC Capital Markets Global Healthcare Conference - PRNewsWire
- 2 months ago - Avantor® to Participate in Bank of America Securities 2025 Health Care Conference - PRNewsWire
- 2 months ago - Avantor Analysts Cut Their Forecasts After Q1 Results - Benzinga
- 2 months ago - Avantor: A Healthier Diagnosis As Expectations Cool - Seeking Alpha
- 2 months ago - Avantor Sees Steady Earnings, Plans Leadership Change And Strategy Shift - Benzinga
- 2 months ago - Avantor Stock Plummets as Firm's CEO Set to Leave Amid Sales Slump, Outlook Cut - Investopedia